Some people eat cheeseburgers like they're training for the Olympics and still fit into their high school jeans. For the rest of us, a single donut seems to teleport directly to our midsection. Is this fair? Absolutely not. But here's the thing: it's not just about willpower. About 1 in 3,000 people are walking around with a genetic "get out of obesity free" card, and scientists just figured out exactly which brain cells are responsible for cashing it in.

The Lucky Few (and Their "Broken" Gene)

Back in 2021, researchers sequenced the genomes of nearly 650,000 people and stumbled onto something remarkable. A small subset of individuals had mutations that essentially broke their GPR75 gene - a receptor that sits on the surface of cells and picks up signals from the environment. You'd think breaking a gene would be bad news. Nope. These folks weighed about 12 pounds less on average and had a 54% lower risk of obesity than everyone else. They weren't doing anything special. Their cells just... forgot how to get the memo that said "store more fat."

GPR75 belongs to a family of proteins called G protein-coupled receptors (GPCRs), which are basically the cell's antenna system. These receptors are so important that about 35% of all approved drugs target them. So when scientists find a GPCR where breaking it makes you healthier, pharmaceutical companies start circling like sharks who just smelled blood in the water.

But Wait - Which Cells Actually Matter?

Here's where the new study from the Elmquist lab at UT Southwestern gets interesting. GPR75 shows up all over the body - brain, liver, fat tissue, you name it. So if you're a drug company trying to build a pill that mimics these lucky mutations, you need to know which GPR75-expressing cells are actually doing the heavy lifting.

The researchers created mice with a clever genetic trick: they could delete GPR75 from specific cell types, like choosing which apps to uninstall from your phone. When they removed GPR75 from glutamatergic neurons - the brain's main "go!" signals that use glutamate to communicate - the mice became resistant to weight gain on a high-fat diet. But when they deleted GPR75 from GABAergic neurons (the "stop!" signals), nothing happened. The mice got just as chunky as normal mice.

Then came the real proof. The team did the experiment backwards: they took mice with GPR75 completely deleted everywhere (the skinny ones) and reactivated the gene only in glutamatergic neurons. Boom - the mice got fat again on a high-fat diet. Reactivate it only in GABAergic neurons? Still skinny.

It's the Eating, Not the Burning

So what's actually different about these mice? You might guess they're running on tiny mouse treadmills or have turbocharged metabolisms. But no. The male mice with GPR75 deleted from glutamatergic neurons simply ate less food when given a high-fat diet. Their energy expenditure stayed the same. They just weren't as interested in gorging themselves.

This makes sense when you consider how the brain's feeding circuits work. Glutamatergic neurons in areas like the lateral hypothalamus and paraventricular nucleus act as brakes on feeding behavior. They're the neurons that eventually tell you, "Okay, that's enough pizza." GPR75 appears to be modulating these circuits in a way that, when it's working normally, keeps your appetite turned up just a notch higher than necessary.

Why Drug Companies Are Salivating

Unlike current weight-loss drugs like Ozempic and Wegovy (GLP-1 receptor agonists), which can cause up to 10% loss of lean muscle mass, the GPR75 knockout mice maintained their muscle while losing fat. That's a big deal. Nobody wants to end up skinnier but weaker.

Regeneron has already partnered with AstraZeneca to develop small-molecule drugs targeting GPR75, and they're also pursuing antibody and siRNA approaches. No GPR75-targeted therapies have reached human clinical trials yet, but the race is definitely on.

The Bigger Picture

This study doesn't just tell us that GPR75 matters for body weight - we already knew that. What it reveals is the surprising specificity of where it matters. Among all the places GPR75 hangs out in your body, it's specifically the copy sitting in glutamatergic neurons that's running the show. The copies in your fat cells or your GABAergic neurons are apparently just along for the ride.

For the millions of people struggling with obesity, this kind of precision matters. It means future drugs might be able to target the right cells without accidentally messing with everything else. Your brain's "appetite dial" could get adjusted without throwing off the rest of your biology.

Of course, it'll be years before any of this turns into a pill you can take. But somewhere out there, about 1 in 3,000 people are living proof that the concept works. Their "broken" genes have been quietly protecting them from diet-induced obesity their whole lives. Now science is catching up to what their DNA already knew.

References

1. Wyler SC, et al. (2026). GPR75 in glutamatergic neurons regulates body weight. Cell Reports. DOI: 10.1016/j.celrep.2026.117011

2. Akbari P, et al. (2021). Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity. Science. DOI: 10.1126/science.abf8683 | PMCID: PMC10275396

3. Zhang Y, et al. (2025). GPR75: A Newly Identified Receptor for Targeted Intervention in the Treatment of Obesity and Metabolic Syndrome. Int J Mol Sci. PMCID: PMC11808825

4. Kim J, et al. (2025). Lateral hypothalamus and eating: cell types, molecular identity, anatomy, temporal dynamics and functional roles. Exp Mol Med. DOI: 10.1038/s12276-025-01451-y

5. Stamatakis AM, et al. (2016). Lateral Hypothalamic Area Glutamatergic Neurons and Their Projections to the Lateral Habenula Regulate Feeding and Reward. J Neurosci. PMCID: PMC4710762

Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.